Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis Publisher Pubmed



Chiappetta S¹ ; Lainas P^{2, 3} ; Kassir R^{4, 5} ; Valizadeh R⁶ ; Bosco A¹ ; Kermansaravi M⁷
Source: Obesity Surgery Published:2022

Abstract

This systematic review evaluates the indications and results of revisional bariatric surgery (RBS) in gastroesophageal reflux disease (GERD). A systematic literature search and meta-analysis was performed for articles published by April 1, 2021. After examining 722 papers involving 17,437 patients, 48 studies were included (n = 915 patients). RBS for GERD was mostly reported after sleeve gastrectomy (n = 796, 87%) and one anastomosis gastric bypass (n = 62, 6.8%) and was performed due to intractable GERD (71.6%), GERD and weight issues (16%), and biliary reflux (6.2%). Mean follow-up of the studies was 31.5 (3–84) months. Pooled estimation of a meta-analysis of studies reported 7% of GERD following primary surgery needing RBS, in which 99% of the patients experienced remission. Graphical abstract: [Figure not available: see fulltext.] © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.